Schippling, Sven

The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment

Tewarie, P., Balk, L., Costello, F., Green, A., Martin, R., Schippling, S., & Petzold, A. (2012) · PLoS ONE

Multiple Sclerosis Research StudiesRetinal Imaging and Analysis

Cited by 627

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

Neuromyelitis Optica Study Group (NEMOS), Trebst, C., Jarius, S., Berthele, A., Paul, F., Schippling, S., Wildemann, B., Borisow, N., Kleiter, I., Aktas, O., et al. (2014) · Journal of Neurology

Multiple Sclerosis Research StudiesOcular Diseases and Behçet’s Syndrome

Cited by 595

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings

Coles, A. J., Cohen, J. A., Fox, E. J., Giovannoni, G., Hartung, H.-P., Havrdova, E., Schippling, S., Selmaj, K. W., Traboulsee, A., Compston, D. A. S., et al. (2017) · Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 277

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography

Bennett, J., de Seze, J., Lana-Peixoto, M., Palace, J., Waldman, A., Schippling, S., Tenembaum, S., Banwell, B., Greenberg, B., Levy, M., et al. (2015) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 252

Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy

Havrdova, E., Arnold, D. L., Cohen, J. A., Hartung, H.-P., Fox, E. J., Giovannoni, G., Schippling, S., Selmaj, K. W., Traboulsee, A., Compston, D. A. S., et al. (2017) · Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 221

Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma

Kontush, A., Berndt, C., Weber, W., Akopyan, V., Arlt, S., Schippling, S., & Beisiegel, U. (2001) · Free Radical Biology and Medicine

Alzheimer's disease research and treatmentsAntioxidant Activity and Oxidative Stress

Cited by 180

Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study

Paul, F., Calabresi, P. A., Barkhof, F., Green, A. J., Kardon, R., Sastre‐Garriga, J., Schippling, S., Vermersch, P., Saidha, S., Gerendas, B. S., et al. (2021) · Annals of Clinical and Translational Neurology

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 98

snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses

Macnair, W., Calini, D., Agirre, E., Bryois, J., Jäkel, S., Smith, R. S., Kukanja, P., Stokar-Regenscheit, N., Ott, V., Foo, L. C., et al. (2025) · Neuron

Multiple Sclerosis Research StudiesSingle-cell and spatial transcriptomics

Cited by 88

Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis

Guadalupi, L., Mandolesi, G., Vanni, V., Balletta, S., Caioli, S., Pavlovic, A., De Vito, F., Fresegna, D., Sanna, K., Vitiello, L., et al. (2024) · Neuropharmacology

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 22

Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis

Wicki, C. A., Hanson, J. V. M., & Schippling, S. (2018) · Current Opinion in Neurology

Multiple Sclerosis Research StudiesGlaucoma and retinal disorders

Cited by 16